Long term efficacy and safety of sacubitril/valsartan in chronic heart failure patients with reduced ejection fraction: a prospective real-world study.
Event:
ESC Congress 2025
Topic:
Heart Failure with Reduced Ejection Fraction (HFrEF)
Session:
Novel insights into heart failure therapy
